Nexscient, Inc. - 8-K Filing
Nexscient reports Q3 2026 revenue of $1.16M with gross margin expansion to 41% and narrowing net loss.
Tickers: $NXNT
Read the full article at SEC EDGAR
Part of the story Rockwell Medical Reports Q3 2026 Results and Announces Vantive Limited Acquisition (3 articles)